S. Dugnani

660 total citations
29 papers, 537 citations indexed

About

S. Dugnani is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, S. Dugnani has authored 29 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 12 papers in Epidemiology and 11 papers in Molecular Medicine. Recurrent topics in S. Dugnani's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (11 papers) and Pneumonia and Respiratory Infections (9 papers). S. Dugnani is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (11 papers) and Pneumonia and Respiratory Infections (9 papers). S. Dugnani collaborates with scholars based in Italy and United States. S. Dugnani's co-authors include F. Fraschini, F. Scaglione, Francesco Scaglione, G. Demartini, F. Ferrara, G Santoro, Valeria Lucini, Giuseppe Pintucci, Giuseppina Maccarinelli and Marco Mor and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Journal of Antimicrobial Chemotherapy.

In The Last Decade

S. Dugnani

29 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Dugnani Italy 12 202 153 116 89 63 29 537
Zélia Menezes‐Garcia Brazil 16 300 1.5× 183 1.2× 35 0.3× 22 0.2× 25 0.4× 24 768
Alireza Abdollahi Iran 12 125 0.6× 50 0.3× 36 0.3× 26 0.3× 20 0.3× 57 477
Kuljit Singh India 17 356 1.8× 260 1.7× 42 0.4× 17 0.2× 21 0.3× 62 1.1k
Hidehito Matsui Japan 16 253 1.3× 189 1.2× 143 1.2× 64 0.7× 107 1.7× 71 807
Alexander I. Kuzmenko United States 12 201 1.0× 99 0.6× 45 0.4× 75 0.8× 22 0.3× 15 762
Gregory B. Cole Canada 9 363 1.8× 27 0.2× 30 0.3× 26 0.3× 44 0.7× 19 619
J Salducci France 13 156 0.8× 91 0.6× 36 0.3× 59 0.7× 6 0.1× 41 1.3k
Kitti Intuyod Thailand 15 159 0.8× 55 0.4× 16 0.1× 56 0.6× 46 0.7× 49 531
Dennis S. Huang United States 17 109 0.5× 80 0.5× 59 0.5× 11 0.1× 39 0.6× 32 656
Vandana Sharma United States 10 548 2.7× 54 0.4× 21 0.2× 15 0.2× 56 0.9× 12 868

Countries citing papers authored by S. Dugnani

Since Specialization
Citations

This map shows the geographic impact of S. Dugnani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Dugnani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Dugnani more than expected).

Fields of papers citing papers by S. Dugnani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Dugnani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Dugnani. The network helps show where S. Dugnani may publish in the future.

Co-authorship network of co-authors of S. Dugnani

This figure shows the co-authorship network connecting the top 25 collaborators of S. Dugnani. A scholar is included among the top collaborators of S. Dugnani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Dugnani. S. Dugnani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pani, Arianna, Valeria Lucini, S. Dugnani, & Francesco Scaglione. (2022). Erdosteine enhances antibiotic activity against bacteria within biofilm. International Journal of Antimicrobial Agents. 59(3). 106529–106529. 9 indexed citations
2.
Spadoni, Gilberto, Annalida Bedini, Michele Mari, et al.. (2018). Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit. Journal of Medicinal Chemistry. 61(17). 7902–7916. 22 indexed citations
3.
Scaglione, Francesco, Valeria Lucini, S. Dugnani, & Arianna Pani. (2018). Comparative Emergence of Resistance to Clofoctol, Erythromycin, and Amoxicillin against Community-Acquired Bacterial Respiratory Tract Pathogens in Italy. Chemotherapy. 63(6). 330–337. 2 indexed citations
4.
Calastretti, Angela, G. Gatti, Valeria Lucini, et al.. (2018). Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells. International Journal of Molecular Sciences. 19(5). 1505–1505. 20 indexed citations
5.
Lucini, Valeria, et al.. (2014). Antibiotics counteract the worsening of airway remodelling induced by infections in asthma. International Journal of Antimicrobial Agents. 43(5). 442–450. 3 indexed citations
6.
Rivara, Silvia, Daniele Pala, Alessio Lodola, et al.. (2012). MT1‐Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N‐{[(3‐O‐Substituted)anilino]alkyl}amides. ChemMedChem. 7(11). 1954–1964. 25 indexed citations
7.
Scaglione, Francesco, et al.. (2012). In vitroandin vivopharmacokinetic/pharmacodynamic activity of clofoctol. Journal of Chemotherapy. 24(4). 201–206. 3 indexed citations
8.
Scaglione, Francesco, et al.. (2012). Comparison of the potency of 10 different brands of Serenoa repens extracts.. PubMed. 16(5). 569–74. 23 indexed citations
9.
Bedini, Annalida, Simone Lucarini, Gilberto Spadoni, et al.. (2011). Toward the Definition of Stereochemical Requirements for MT2-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives. Journal of Medicinal Chemistry. 54(24). 8362–8372. 20 indexed citations
10.
Scaglione, Francesco, G. Demartini, S. Dugnani, & F. Fraschini. (2000). In vitro Comparative Dynamics of Modified-Release Clarithromycin and of Azithromycin. Chemotherapy. 46(5). 342–352. 2 indexed citations
12.
Scaglione, F., et al.. (1996). Ceftibuten concentrations in human tonsillar tissue. European Journal of Clinical Microbiology & Infectious Diseases. 15(12). 940–943. 2 indexed citations
14.
Scaglione, F., S. Dugnani, & F. Fraschini. (1995). Once-a-Day Cephalosporins: Reality or Myth?. Journal of Chemotherapy. 7(sup1). 13–15. 1 indexed citations
15.
Scaglione, F., G. Demartini, S. Dugnani, et al.. (1994). Effect of Antibiotics on <i>Bordetella pertussis</i> Adhering Activity: Hypothesis Regarding Mechanism of Action. Chemotherapy. 40(3). 215–220. 5 indexed citations
16.
Scaglione, Francesco, G. Demartini, S. Dugnani, & F. Fraschini. (1993). A New Model Examining Intracellular and Extracellular Activity of Amoxicillin, Azithromycin, and Clarithromycin in Infected Cells. Chemotherapy. 39(6). 416–423. 40 indexed citations
17.
Scaglione, Francesco, Gianfranco Tassi, Giuseppina Maccarinelli, et al.. (1993). Penetration of Clarithromycin into Oral and Respiratory Tissues. Clinical Drug Investigation. 6(2). 104–109. 5 indexed citations
18.
Fraschini, F., F. Scaglione, Giuseppe Pintucci, et al.. (1991). The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans. Journal of Antimicrobial Chemotherapy. 27(suppl A). 61–65. 87 indexed citations
19.
Fraschini, F., F. Scaglione, Mario Falchi, et al.. (1990). Pharmacokinetics and Tissue Distribution of Amoxicillin plus Clavulanic Acid after Oral Administration in Man. Journal of Chemotherapy. 2(3). 171–177. 31 indexed citations
20.
Fraschini, F., F. Scaglione, F. Ferrara, et al.. (1989). Miokamycin and Leukocyte Activity in Man. Chemotherapy. 35(4). 289–295. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026